[Do anabolic steroids protect bone marrow during cytostatic therapy?].
D045930:Anabolic Agents / Q000008:administration & dosage*; D000731:Androstanes / Q000008:administration & dosage; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001792:Blood Platelets / Q000187:drug effects; D004359:Drug Therapy, Combination; D004920:Erythropoiesis / Q000187:drug effects; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D009277:Nandrolone / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077603:Nandrolone Decanoate; D009369:Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000008:administration & dosage
D045930:Anabolic Agents; D000731:Androstanes; D000970:Antineoplastic Agents; D013739:Testosterone; D009277:Nandrolone; D000077603:Nandrolone Decanoate; C008580:nandrolone phenpropionate
Schützen Anabolika das Knochenmark bei zytostatischer Therapie?